Patents by Inventor Raymond Dagger

Raymond Dagger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8558017
    Abstract: Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran,deprotonated 1,2-cyclohexanediamino-N,N?-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: October 15, 2013
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: David E. Pereira, Wade Aumiller, Raymond Dagger
  • Publication number: 20130023662
    Abstract: Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N?-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2.
    Type: Application
    Filed: December 12, 2011
    Publication date: January 24, 2013
    Applicant: VANDA PHARMECEUTICALS INC.
    Inventors: David E. Pereira, Wade Aumiller, Raymond Dagger
  • Publication number: 20120149906
    Abstract: Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N?-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2.
    Type: Application
    Filed: December 12, 2011
    Publication date: June 14, 2012
    Applicant: VANDA PHARMECEUTICALS INC.
    Inventors: David E. Pereira, Wade Aumiller, Raymond Dagger
  • Patent number: 8097738
    Abstract: Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N?-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: January 17, 2012
    Assignee: VANDA Pharmaceuticals Inc.
    Inventors: David E. Pereira, Wade Aumiller, Raymond Dagger
  • Publication number: 20100228039
    Abstract: Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N?-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2.
    Type: Application
    Filed: May 20, 2010
    Publication date: September 9, 2010
    Applicant: VANDA PHARMECEUTICALS INC.
    Inventors: David E. Pereira, Wade Aumiller, Raymond Dagger
  • Patent number: 7754902
    Abstract: Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N?-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2.
    Type: Grant
    Filed: May 18, 2006
    Date of Patent: July 13, 2010
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: David E. Pereira, Wade Aumiller, Raymond Dagger
  • Publication number: 20070270593
    Abstract: Chiral ruthenium catalysts comprising salen and alkenyl ligands are provided for stereoselective cyclopropanation, and methods of cyclopropanation are provided. The chiral ruthenium catalyst is prepared in situ by combining an alkenyl ligand, a deprotonated chiral salen ligand, and a ruthenium (II) metal. A preferred catalyst is prepared in situ by combining 2,3-dihydro-4-venylbenzofuran, deprotonated 1,2-cyclohexanediamino-N,N?-bis(3,5-di-t-butyl-salicylidene) and RuCl2(p-cymene)]2.
    Type: Application
    Filed: May 18, 2006
    Publication date: November 22, 2007
    Inventors: David E. Pereira, Wade Aumiller, Raymond Dagger
  • Publication number: 20070177957
    Abstract: The present invention is a housing for a surface-mountable device such as a security device (a PIR, a microwave motion detector, and the like). The housing has a surface-mountable housing portion with at least one aperture for receiving a surface-mounting member therethrough, the housing portion fabricated substantially from a plastic material. A member-retaining portion is integrally molded with the housing portion and extends substantially perpendicular from said housing portion, said member-retaining portion adapted to receive a surface-mounting member when inserted therethrough and retain said surface-mounting member in place. As a result of this configuration, when a surface-mounting member such as a screw is inserted therethrough, the surface-mounting member is held in place by the member-retaining portion and is insertable through the aperture when pressure is applied thereto.
    Type: Application
    Filed: January 31, 2006
    Publication date: August 2, 2007
    Inventors: Raymond Daggers, John Kovach